Derma Has Foot in Door in Chronic Wound Care Race
Derma Sciences Inc., of Princeton, N.J., is taking an important step in development of a therapy for a tough indication – diabetic foot ulcer. It began enrolling patients in the first of two Phase III trials of its topical drug candidate, DSC127.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter